Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 26, 2022, to report its financial results for the third quarter ended September 30, 2022. The core of this filing is the press release announcing these results, furnished as Exhibit 99.1. While the 8-K itself doesn't detail the specific financial figures, it directs investors to the accompanying press release for comprehensive information on the company's operational performance and financial condition during the third quarter. Investors should refer to Exhibit 99.1 for details on revenue, profitability, segment performance, and any forward-looking guidance provided by the company.
Key Highlights
- 1Boston Scientific Corporation (BSX) released its Q3 2022 financial results on October 26, 2022.
- 2The 8-K filing's primary purpose was to furnish the Q3 2022 earnings press release (Exhibit 99.1).
- 3Investors can find detailed financial performance and operational results in the furnished press release.
- 4The filing does not contain the specific Q3 2022 financial metrics itself, but points to Exhibit 99.1 for this information.
- 5The information presented is subject to the standard disclaimer regarding its 'furnished' status, not 'filed', under SEC regulations.
- 6No other material events or business updates were reported in this specific 8-K filing beyond the Q3 earnings release.